Mountlake Terrace, WA, United States of America

Kevin Church

This inventor holds 1 USPTO granted patent and 9 published patent applications. Top assignee: Athira Pharma, Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kevin Church. Retrieved from https://idiyas.com/inventor/kevin-church

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kevin Church: Innovating Treatments for Parkinson's Disease

Introduction: Kevin Church is a prominent inventor based in Mountlake Terrace, Washington, with a significant contribution to the field of medicine. He holds one patent that addresses critical issues related to Parkinson's disease and Lewy body disorders. His innovation reflects a deep commitment to developing effective therapeutic methods for those affected by these debilitating conditions.

Latest Patents: Kevin's notable patent, titled "Methods of treating Parkinson's disease and/or Lewy body disease or disorder(s)," focuses on a groundbreaking method for administering a compound known as ATH-1017. This innovative approach aims to improve the treatment of Parkinson's disease dementia as well as dementia associated with Lewy bodies. This patent highlights Kevin's dedication to enhancing the quality of life for patients suffering from these neurodegenerative disorders.

Career Highlights: Kevin Church is affiliated with Athira Pharma, Inc., a company known for its focus on developing novel therapies for central nervous system disorders. His work at Athira not only showcases his expertise but also reinforces the company's commitment to advancing medical treatment options. Kevin's contributions have been pivotal in pushing the boundaries of research in therapeutic methods for neurodegenerative diseases.

Collaborations: Throughout his career, Kevin has had the opportunity to collaborate with notable colleagues, including Hans J. Moebius and Xue Hua. These partnerships enable a broader exchange of ideas and innovations, further enriching the research community's efforts in finding effective solutions for complex medical challenges.

Conclusion: Kevin Church stands out as a dedicated inventor whose work has the potential to make a significant impact on the treatment of Parkinson's disease and related disorders. With his innovative patent and collaborative spirit, he continues to contribute to the advancement of medical science, offering hope to many who are affected by these challenging conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…